Celecoxib: all 393 studies that test it

Page 4 of 4. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug EfficacyActive, not recruitingNCT00268476Phase 2/3
• A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the StomachCompletedNCT00261586Phase 4
• Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal CancerCompletedNCT00258232Phase 2
• Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction CarcinomaTerminatedNCT00256321Phase 2
• A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine CancersTerminatedNCT00231829Phase 2
• Combination Chemotherapy Treatments in Patients With Metastatic Colorectal CancerCompletedNCT00230399Phase 2
• Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
• A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerStatus unknownNCT00218205Phase 2
• A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerStatus unknownNCT00215345Phase 2
• A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839CompletedNCT00212108Phase 1/2
• Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC PatientsSuspendedNCT00211952Phase 3
• Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced WalkCompletedNCT00194090Phase 4
• Celebrex With Preoperative Chemoradiation - Rectal CancerCompletedNCT00188565Phase 1/2
• A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal CancerTerminatedNCT00183807Phase 2
• Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLCCompletedNCT00181532Phase 2
• Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic CancerTerminatedNCT00177853Phase 1
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
• Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The HipCompletedNCT00174317Phase 4
• A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive CancerCompletedNCT00165451Phase 2
• Effect Of Celecoxib On Hip Osteoarthritis (OA) ProgressionTerminatedNCT00163241Phase 3
• Effect of Selective COX-2 Inhibition on Ulcer HealingCompletedNCT00153673Phase 3
• Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis PatientsCompletedNCT00153660Phase 3
• Celebrex - Cervix: Celecoxib in the Treatment of Patients With Locally Advanced Carcinoma of the CervixCompletedNCT00152828Phase 1/2
• Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological SurgeryCompletedNCT00150280Phase 3
• Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In JapanCompletedNCT00141154Phase 3
• Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal CancerCompletedNCT00137852Phase 2
• Celebrex Short Versus Long Therapy In Osteoarthritis Of The KneeCompletedNCT00137410Phase 3
• Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy PopulationCompletedNCT00137033Phase 4
• Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate CancerCompletedNCT00136487Phase 2/3
• Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients With Invasive Breast CancerCompletedNCT00135018Phase 2
• Celecoxib Treatment for Lung CancerWithdrawnNCT00108186Phase 1
• Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00104767Phase 1
• Celecoxib in Preventing Head and Neck Cancer in Patients With Oral LeukoplakiaCompletedNCT00101335Phase 2
• Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast CancerTerminatedNCT00101062Phase 2
• Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWithdrawnNCT00093678Not applicable
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)CompletedNCT00092781Phase 3
• A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)CompletedNCT00092768Phase 3
• Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00088959Phase 1
• Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the ColonCompletedNCT00085163Phase 3
• Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal CancerCompletedNCT00084721Phase 1
• Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWithdrawnNCT00084578Not applicable
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00084448Phase 2
• Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic OophorectomyWithdrawnNCT00084370Not applicable
• Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumTerminatedNCT00081224Phase 2
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesTerminatedNCT00080782Phase 2
• Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast CancerTerminatedNCT00075673Phase 1
• Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical ProstatectomyTerminatedNCT00073970Phase 2
• Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00073866Phase 1/2
• Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal CancerStatus unknownNCT00072553Phase 2
• S0212 Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the CervixWithdrawnNCT00072540Phase 2
• Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00072072Phase 1
• Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00070486Phase 2
• Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast CancerCompletedNCT00070057Phase 1
• Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung CancerCompletedNCT00068653Phase 2
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the EsophagusCompletedNCT00066716Phase 2
• Treatment of Diabetic NephropathyTerminatedNCT00065559Not applicable
• Delaying Alzheimer Disease Symptoms With Anti-Inflammatory DrugsCompletedNCT00065169Not applicable
• Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
• Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung CancerCompletedNCT00062179Phase 2
• Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung CancerCompletedNCT00062101Phase 2
• Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid CancerCompletedNCT00061906Phase 2
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00058006Phase 2
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaCompletedNCT00057980Phase 1/2
• Celecoxib in Preventing Breast Cancer in At-Risk Premenopausal WomenCompletedNCT00056082Phase 2
• Celecoxib in Preventing Lung Cancer in Former Heavy SmokersCompletedNCT00055978Phase 2
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaCompletedNCT00052611Phase 2
• Laser and Medical Treatment of Diabetic Macular EdemaCompletedNCT00050479Phase 3
• Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeCompletedNCT00047294Phase 2
• Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant GliomaCompletedNCT00047281Phase 2
• Celecoxib in Treating Women With Metastatic or Recurrent Breast CancerTerminatedNCT00045591Phase 2
• Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic TherapyCompletedNCT00043680Phase 2
• Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal NeoplasiaCompletedNCT00043043Phase 2
• Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural MalignanciesCompletedNCT00037817Phase 1
• For Prevention of Diarrhea in Patients Diagnosed With Metastatic Colorectal Cancer Treated With ChemotherapyTerminatedNCT00037180Phase 2
• Chemoprevention of Oral Premalignant LesionsCompletedNCT00036283Phase 2
• Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00030420Phase 2
• Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung CancerCompletedNCT00030407Phase 2
• Celecoxib in Preventing Skin Cancer in Patients With Actinic KeratosesWithdrawnNCT00027976Phase 2/3
• Celecoxib in Preventing Skin CancerWithdrawnNCT00025051Phase 2
• Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical CancerCompletedNCT00023660Phase 1/2
• Celecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus SyndromeCompletedNCT00023621Phase 2
• Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00022399Phase 2
• Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco SmokersCompletedNCT00020878Phase 2
• Celecoxib in Treating Patients With Precancerous Lesions of the MouthCompletedNCT00014404Phase 2
• Anti-Inflammatory Treatment for Age-Associated Memory Impairment: A Double-Blind Placebo-Controlled TrialCompletedNCT00009230Phase 3
• Celecoxib and Trastuzumab in Treating Women With Metastatic Breast CancerCompletedNCT00006381Phase 2
• Celebrex for Pain Relief After Oral SurgeryCompletedNCT00006299Phase 2
• Celecoxib in Treating Patients With Bladder CancerCompletedNCT00006124Phase 2/3
• Celecoxib to Prevent Cancer in Patients With Barrett's EsophagusCompletedNCT00005878Phase 2
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove PolypsCompletedNCT00005094Phase 3
• Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)CompletedNCT00001955Phase 2
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and CarriersCompletedNCT00001693Phase 1

← Celecoxib overview